Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Virol ; 74(22): 10729-36, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11044117

ABSTRACT

The UL97 protein (pUL97) of human cytomegalovirus (HCMV) is a protein kinase that also phosphorylates ganciclovir (GCV), but its biological function is not yet clear. The M97 protein (pM97) of mouse cytomegalovirus (MCMV) is the homolog of pUL97. First, we studied the consequences of genetic replacement of M97 by UL97. Using the infectious bacterial plasmid clone of the full-length MCMV genome (M. Wagner, S. Jonjic, U. H. Koszinowski, and M. Messerle, J. Virol. 73:7056-7060, 1999), we replaced the M97 gene with the UL97 gene and constructed an MCMV M97 deletion mutant and a revertant virus. In addition, pUL97 and pM97 were expressed by recombinant vaccinia virus to compare both for known functions. Remarkably, pM97 proved not to be the reason for the GCV sensitivity of MCMV. When expressed by the recombinant MCMV, however, pUL97 was phosphorylated and endowed MCMV with the capacity to phosphorylate GCV, thereby rendering MCMV more susceptible to GCV. We found that deletion of pM97, although it is not essential for MCMV replication, severely affected virus growth. This growth deficit was only partially amended by pUL97 expression. When expressed by recombinant vaccinia viruses, both proteins were phosphorylated and supported phosphorylation of GCV, but pUL97 was about 10 times more effective than pM97. One hint of the functional differences between the proteins was provided by the finding that pUL97 accumulates in the nucleus, whereas pM97 is predominantly located in the cytoplasm of infected cells. In vivo testing revealed that the UL97-MCMV recombinant should allow evaluation of novel antiviral drugs targeted to the UL97 protein of HCMV in mice.


Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus/metabolism , Ganciclovir/pharmacology , Muromegalovirus/metabolism , Phosphotransferases (Alcohol Group Acceptor)/metabolism , Vaccinia virus/metabolism , Animals , Antiviral Agents/metabolism , Cells, Cultured , Cytomegalovirus/drug effects , Cytomegalovirus/genetics , Ganciclovir/metabolism , Gene Deletion , Herpesviridae Infections/physiopathology , Herpesviridae Infections/virology , Humans , Mice , Mice, Inbred BALB C , Muromegalovirus/drug effects , Muromegalovirus/genetics , Muromegalovirus/pathogenicity , Phosphorylation , Phosphotransferases (Alcohol Group Acceptor)/genetics , Recombinant Proteins/metabolism , Recombination, Genetic , Vaccinia virus/genetics , Virus Replication
2.
Intervirology ; 42(5-6): 357-64, 1999.
Article in English | MEDLINE | ID: mdl-10702718

ABSTRACT

The influence of human cytomegalovirus (HCMV) on the transcription of 11 selected, representative extracellular matrix genes was investigated in cell culture. Northern blot hybridization indicated the downregulation of all mRNAs investigated. Based on our results and the known repression of other extracellular matrix transcripts and the beta-actin transcription during HCMV infection, we suggest that one molecular mechanism contributing to the cytopathic effect may be the transcriptional downregulation of genes encoding proteins involved in cell structure and intercellular connection. To further study the biological relevance of this and other pathogenetic mechanisms, we established a human renal artery organ culture system and characterized this new infection model for HCMV. Our model is a new suitable system for the investigation of molecular as well as functional consequences of HCMV infection in a more physiological microenvironment.


Subject(s)
Cytomegalovirus Infections/virology , Cytomegalovirus/physiology , Extracellular Matrix Proteins/genetics , Renal Artery/virology , Cells, Cultured , Cytomegalovirus Infections/metabolism , Cytomegalovirus Infections/pathology , Cytopathogenic Effect, Viral , Extracellular Matrix/metabolism , Extracellular Matrix Proteins/biosynthesis , Gene Expression Regulation , Humans , Models, Biological , Organ Culture Techniques , Renal Artery/metabolism
3.
J Cell Sci ; 111 ( Pt 21): 3157-66, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9763510

ABSTRACT

Putative protein synthesizing domains, called plaques, are characterized in the squid giant synapse and axon and in terminals of squid photoreceptor neurons. Plaques are oval-shaped formations of about 1 microm in size, which (1) generate signals that have spectroscopic electron energy loss characteristics of ribosomes, (2) exhibit ribonuclease-sensitive binding of YOYO-1, a fluorescent RNA/DNA dye, and (3) in part hybridize with a poly(dT) oligonucleotide. In the giant synapse plaques are abundant in the postsynaptic area, but are absent in the presynaptic terminal. In the cortical layer of the optic lobes, plaques are localized in the large carrot-shaped presynaptic terminals of photoreceptor neurons, where they are surrounded by synaptic vesicles and mitochondria. Biochemical and autoradiographic data have documented that the protein synthetic activity of squid optic lobe synaptosomes is largely due to the presynaptic terminals of the photoreceptor neurons. The identification of ribosomes and poly(A+)-mRNA in the plaques indicates that these structures are sites of local protein synthesis in synaptic domains.


Subject(s)
Nerve Tissue Proteins/biosynthesis , Neurons/metabolism , Optic Lobe, Nonmammalian/cytology , Photoreceptor Cells, Invertebrate/cytology , Synapses/metabolism , Animals , Benzoxazoles , Decapodiformes , Fluorescent Dyes , Neurons/ultrastructure , Optic Lobe, Nonmammalian/metabolism , Photoreceptor Cells, Invertebrate/metabolism , Presynaptic Terminals/metabolism , Quinolinium Compounds , Spectrum Analysis , Synapses/ultrastructure , Visual Pathways
SELECTION OF CITATIONS
SEARCH DETAIL